期刊
CHEMICAL RESEARCH IN TOXICOLOGY
卷 32, 期 6, 页码 1087-1095出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.chemrestox.8b00400
关键词
-
资金
- Cancer Institute of New Jersey
- New Jersey Health Foundation
- National Institute of Environmental Health Sciences [P30 ES005022]
- National Institute of Neurological Disorders and Stroke [U01 NS108956]
- National Institute of Arthritis and Musculoskeletal and Skin Diseases [U54 AR055073]
- National Cancer Institute [K01 CA189301]
- FDA Center for Tobacco products [K01 CA189301]
- OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U01NS108956] Funding Source: NIH RePORTER
Available studies, while limited in number, suggest that e-cigarette vaping induces oxidative stress, with one potential mechanism being the direct formation of reactive oxygen species (ROS) in e-vapor. In the present studies, we measured the formation of hydroxyl radical ((OH)-O-center dot), the most destructive ROS, in e-vapor under a range of vaping patterns (i.e., power settings, solvent concentrations, flavorings). Study results show that increased power output and puff volume correspond with the formation of significantly higher amounts of (OH)-O-center dot in e-vapor because of elevated coil temperature and oxygen supply. Vegetable glycerin (VG) e-liquids generated higher (OH)-O-center dot levels than propylene glycol (PG) e-liquids, as did flavored e-liquids relative to nonflavored e-liquids. E-vapor in combination with ascorbic acid, which is an abundant biological molecule in human epithelial lining fluid, can also induce (OH)-O-center dot formation. The dose of radical per puff associated with e-cigarette vaping was 10-1000 times lower than the reported dose generated by cigarette smoking. However, the daily average (OH)-O-center dot dose can be comparable to that from cigarette smoking depending on vaping patterns. Overall, e-cigarette users who use VG-based flavored e-cigarettes at higher power output settings may be at increased risk for (OH)-O-center dot exposures and related health consequences such as asthma and chronic obstructive pulmonary disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据